Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 60

1.

Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumour.

Pugashetti N, Yap SA, Lara PN Jr, Gandour-Edwards R, Dall'Era MA.

Can Urol Assoc J. 2015 Mar-Apr;9(3-4):E204-7. doi: 10.5489/cuaj.2447.

2.

What is the Optimal Way to Select Candidates for Active Surveillance of Prostate Cancer?

Dall'Era M, Carroll P.

J Urol. 2015 Jun 14. pii: S0022-5347(15)04201-9. doi: 10.1016/j.juro.2015.06.069. [Epub ahead of print] No abstract available.

PMID:
26079332
3.

Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome.

Dall'Era M, Levesque V, Solomons N, Truman M, Wofsy D.

Lupus Sci Med. 2015 May 20;2(1):e000089. doi: 10.1136/lupus-2015-000089. eCollection 2015.

4.

Nanotechnology in bladder cancer: current state of development and clinical practice.

Tomlinson B, Lin TY, Dall'Era M, Pan CX.

Nanomedicine (Lond). 2015;10(7):1189-201. doi: 10.2217/nnm.14.212.

PMID:
25929573
5.

Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis.

Nguyen HG, Tilki D, Dall'Era MA, Durbin-Johnson B, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Espinós EL, Mandel P, Martinez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Rodriguez-Faba O, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP.

J Urol. 2015 Mar 19. pii: S0022-5347(15)03386-8. doi: 10.1016/j.juro.2015.02.2948. [Epub ahead of print]

PMID:
25797392
6.

Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus.

Aranow C, Kamen DL, Dall'Era M, Massarotti EM, Mackay MC, Koumpouras F, Coca A, Chatham WW, Clowse ME, Criscione-Schreiber LG, Callahan S, Goldmuntz EA, Keyes-Elstein L, Oswald M, Gregersen PK, Diamond B.

Arthritis Rheumatol. 2015 Jul;67(7):1848-57. doi: 10.1002/art.39108.

PMID:
25777546
7.

Patient and disease factors affecting the choice and adherence to active surveillance.

Dall'Era MA.

Curr Opin Urol. 2015 May;25(3):272-6. doi: 10.1097/MOU.0000000000000154.

PMID:
25692724
8.

Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort.

Dall'Era M, Cisternas MG, Smilek DE, Straub L, Houssiau FA, Cervera R, Rovin BH, Mackay M.

Arthritis Rheumatol. 2015 May;67(5):1305-13. doi: 10.1002/art.39026.

PMID:
25605554
9.

Ultrasensitive prostate specific antigen and its role after radical prostatectomy: a systematic review.

Tilki D, Kim SI, Hu B, Dall'Era MA, Evans CP.

J Urol. 2015 May;193(5):1525-31. doi: 10.1016/j.juro.2014.10.087. Epub 2014 Oct 22. Review.

PMID:
25444980
10.

Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer.

Zargar H, Espiritu PN, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Gandhi NM, Griffin J, Montgomery JS, Vasdev N, Yu EY, Youssef D, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Garcia JA, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black PC.

Eur Urol. 2015 Feb;67(2):241-9. doi: 10.1016/j.eururo.2014.09.007. Epub 2014 Sep 23.

PMID:
25257030
11.

Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy.

Tilki D, Hu B, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Linares E, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Thieu W, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP.

J Urol. 2015 Feb;193(2):436-42. doi: 10.1016/j.juro.2014.07.087. Epub 2014 Jul 22.

PMID:
25063493
12.

No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period.

Wu JN, Fish KM, Evans CP, Devere White RW, Dall'Era MA.

Cancer. 2014 Mar 15;120(6):818-23. doi: 10.1002/cncr.28485. Epub 2013 Nov 20.

13.

Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.

Tilki D, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP.

Eur Urol. 2014 Sep;66(3):577-83. doi: 10.1016/j.eururo.2013.06.048. Epub 2013 Jul 10.

PMID:
23871402
14.

Validation study of a computer-based open surgical trainer: SimPraxis(®) simulation platform.

Tran LN, Gupta P, Poniatowski LH, Alanee S, Dall'era MA, Sweet RM.

Adv Med Educ Pract. 2013 Mar 19;4:23-30. doi: 10.2147/AMEP.S38422. Print 2013.

15.

Editorial comment.

Dall'Era M.

J Urol. 2013 Jul;190(1):96. doi: 10.1016/j.juro.2013.01.112. Epub 2013 Apr 25. No abstract available.

PMID:
23624151
16.

The economics of active surveillance for prostate cancer.

Dall'Era MA.

Curr Opin Urol. 2013 May;23(3):278-82. doi: 10.1097/MOU.0b013e32835f4b6b. Review.

PMID:
23449496
17.

A young woman with systemic lupus erythematosus and extensive mesenteric vasculitis involving small and medium vessels.

Ashouri JF, Davis JL, Farkas A, Durack JC, Ramachandran R, Dall'Era M.

Arthritis Care Res (Hoboken). 2012 Dec;64(12):1928-33. doi: 10.1002/acr.21833. No abstract available.

PMID:
22933330
18.

Contemporary management of muscle-invasive bladder cancer.

Dall'Era MA, Cheng L, Pan CX.

Expert Rev Anticancer Ther. 2012 Jul;12(7):941-50. doi: 10.1586/era.12.60. Review.

19.

Active surveillance for prostate cancer: a systematic review of the literature.

Dall'Era MA, Albertsen PC, Bangma C, Carroll PR, Carter HB, Cooperberg MR, Freedland SJ, Klotz LH, Parker C, Soloway MS.

Eur Urol. 2012 Dec;62(6):976-83. doi: 10.1016/j.eururo.2012.05.072. Epub 2012 Jun 7. Review.

PMID:
22698574
20.

Economic analysis of active surveillance for localized prostate cancer.

Kim S 2nd, Dall'Era MA, Evans CP.

Curr Opin Urol. 2012 May;22(3):247-53. doi: 10.1097/MOU.0b013e328351dd32. Review.

PMID:
22388666
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk